» Articles » PMID: 21464949

Placenta Growth Factor-1 Exerts Time-dependent Stabilization of Adherens Junctions Following VEGF-induced Vascular Permeability

Overview
Journal PLoS One
Date 2011 Apr 6
PMID 21464949
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Increased vascular permeability is an early event characteristic of tissue ischemia and angiogenesis. Although VEGF family members are potent promoters of endothelial permeability the role of placental growth factor (PlGF) is hotly debated. Here we investigated PlGF isoforms 1 and 2 and present in vitro and in vivo evidence that PlGF-1, but not PlGF-2, can inhibit VEGF-induced permeability but only during a critical window post-VEGF exposure. PlGF-1 promotes VE-cadherin expression via the trans-activating Sp1 and Sp3 interaction with the VE-cadherin promoter and subsequently stabilizes transendothelial junctions, but only after activation of endothelial cells by VEGF. PlGF-1 regulates vascular permeability associated with the rapid localization of VE-cadherin to the plasma membrane and dephosphorylation of tyrosine residues that precedes changes observed in claudin 5 tyrosine phosphorylation and membrane localization. The critical window during which PlGF-1 exerts its effect on VEGF-induced permeability highlights the importance of the translational significance of this work in that PLGF-1 likely serves as an endogenous anti-permeability factor whose effectiveness is limited to a precise time point following vascular injury. Clinical approaches that would pattern nature's approach would thus limit treatments to precise intervals following injury and bring attention to use of agents only during therapeutic windows.

Citing Articles

Treatment of diabetic retinopathy through neuropeptide Y-mediated enhancement of neurovascular microenvironment.

Ou K, Copland D, Theodoropoulou S, Mertsch S, Li Y, Liu J J Cell Mol Med. 2020; 24(7):3958-3970.

PMID: 32141716 PMC: 7171318. DOI: 10.1111/jcmm.15016.


Placental growth factor negatively regulates retinal endothelial cell barrier function through suppression of glucose-6-phosphate dehydrogenase and antioxidant defense systems.

Huang H, Lennikov A, Saddala M, Gozal D, Grab D, Khalyfa A FASEB J. 2019; 33(12):13695-13709.

PMID: 31585507 PMC: 6894064. DOI: 10.1096/fj.201901353R.


Restoring retinal neurovascular health via substance P.

Ou K, Mertsch S, Theodoropoulou S, Wu J, Liu J, Copland D Exp Cell Res. 2019; 380(2):115-123.

PMID: 30995434 PMC: 6548993. DOI: 10.1016/j.yexcr.2019.04.008.


Retraction: Placenta Growth Factor-1 Exerts Time-Dependent Stabilization of Adherens Junctions Following VEGF-Induced Vascular Permeability.

PLoS One. 2019; 14(1):e0210983.

PMID: 30650141 PMC: 6334994. DOI: 10.1371/journal.pone.0210983.


Regulation of human feto-placental endothelial barrier integrity by vascular endothelial growth factors: competitive interplay between VEGF-Aa, VEGF-Ab, PIGF and VE-cadherin.

Pang V, Bates D, Leach L Clin Sci (Lond). 2017; 131(23):2763-2775.

PMID: 29054861 PMC: 5869853. DOI: 10.1042/CS20171252.


References
1.
Gavard J, Gutkind J . VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol. 2006; 8(11):1223-34. DOI: 10.1038/ncb1486. View

2.
Cai J, Ahmad S, Jiang W, Huang J, Kontos C, Boulton M . Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells. Diabetes. 2003; 52(12):2959-68. DOI: 10.2337/diabetes.52.12.2959. View

3.
Khaliq A, Foreman D, Ahmed A, Weich H, Gregor Z, McLeod D . Increased expression of placenta growth factor in proliferative diabetic retinopathy. Lab Invest. 1998; 78(1):109-16. View

4.
Kowanetz M, Ferrara N . Vascular endothelial growth factor signaling pathways: therapeutic perspective. Clin Cancer Res. 2006; 12(17):5018-22. DOI: 10.1158/1078-0432.CCR-06-1520. View

5.
Autiero M, Waltenberger J, Communi D, Kranz A, Moons L, Lambrechts D . Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med. 2003; 9(7):936-43. DOI: 10.1038/nm884. View